Currently, pricing for drugs under DPCO 2013 is linked to WPI (Wholesale Price Index) while for others an annual hike of up to 10% is allowed. In the near term, the proposed Pharma price index would allow the industry to more effectively set off rising input costs, which WPI does not effectively capture. However, over the longer term, the move seeks to remove the distinction between drugs under price control and outside of it. Essentially, the government's proposal is a covert...